For infection with ADV, Poland has submitted to the Commission information demonstrating that the conditions for recognition of disease-free status from infection with ADV laid down in Delegated Regulation (EU) 2020/689 are fulfilled for all the regions currently listed in Part II of Annex VI to Implementing Regulation (EU) 2021/620 as having an approved eradication programme. Following the assessment by the Commission, that application has been shown to comply with the criteria laid down in Part II, Chapter 4, of Delegated Regulation (EU) 2020/689 for the granting of disease-free status from infection with ADV. Therefore, those zones should be listed in Part I of Annex VI to Implementing Regulation (EU) 2021/620, as having disease-free status from infection with ADV.
Recital 10, Regulation (EU) 2023/1071
In forcesince 1 Jun 2023